# IMPAVIDO

NDC: 69051-300
Generic name: miltefosine
Labeler / Manufacturer: Profounda, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20151029

FDA application: NDA204684

## Active ingredients

- MILTEFOSINE: 50 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69051-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69051-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bcb387ac-2e90-4f5e-94b2-d3635190678e